Skip to main content
. 2019 Nov 5;19(3):e209–e216. doi: 10.18295/squmj.2019.19.03.006

Table 1.

Clinical characteristics of women with non-metastatic triple-negative breast cancer at the Sultan Qaboos University Hospital, Muscat, Oman (N = 79)

Characteristic n (%)
Age in years
<40 25 (31.6)
40–60 46 (58.2)
>60 8 (10.1)
Median (range) 46 (19–74)
Menstrual status
Premenopausal 52 (65.8)
Menopausal 27 (34.2)
Family history of breast cancer
Yes 5 (6.3)
No 66 (83.5)
Unknown 8 (10.1)
Affected side
Left 38 (48.1)
Right 41 (51.9)
Clinical tumour size
Tx 1 (1.3)
T1 6 (7.6)
T2 33 (41.8)
T3 23 (29.1)
T4 15 (19)
Inflammatory breast cancer 1 (1.3)
Clinical node status
N0 41 (51.9)
N1 26 (32.9)
N2 11 (13.9)
N3 1 (1.3)
Clinical stage at presentation
I 5 (6.3)
II 41 (51.9)
III 33 (41.8)

Tx = tumour size could not be ascertained; T1 = tumour of ≤2 cm; T2 = tumour of 2.1–5 cm; T3 = tumour of >5 cm; T4 = tumour of any size invading the chest wall, breast skin (ulceration or macroscopic nodules) or inflammatory carcinoma; N0 = absence of nodal involvement; N1 = metastasis to the ipsilateral axillary lymph nodes that are mobile; N2 = metastasis to the ipsilateral axillary lymph nodes that are fixed; N3 = metastasis to the ipsilateral infra-clavicular lymph nodes with or without axillary lymph nodes.